Asia-Pacific Cancer Vaccines Market Share

Market Share of Asia-Pacific Cancer Vaccines Industry

The Asia-Pacific cancer vaccine market is competitive due to the presence of many companies operating globally and regionally. With the rising research and development, the companies working in this market segment are launching novel products, and more companies are expected to penetrate the market. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Astellas Pharma Inc., AstraZeneca Plc, GlaxoSmithKline Plc, Daiichi Sankyo Company Limited, Serum Institute Inc., Eli Lilly, Merck & Co., Inc., Pfizer Inc., Sanofi, and Bristol-Myers Squibb.

Asia-Pacific Cancer Vaccines Market Leaders

1. Glaxosmithkline Plc

2. Bristol-Myers Squibb

3. Sanofi

4. Eli Lilly

5. AstraZeneca Plc

*Disclaimer: Major Players sorted in no particular order